233 related articles for article (PubMed ID: 18430833)
1. Clinical application of the BI-RADS final assessment to breast sonography in conjunction with mammography.
Kim EK; Ko KH; Oh KK; Kwak JY; You JK; Kim MJ; Park BW
AJR Am J Roentgenol; 2008 May; 190(5):1209-15. PubMed ID: 18430833
[TBL] [Abstract][Full Text] [Related]
2. Influence of age on PPV of sonographic BI-RADS categories 3, 4, and 5.
Fu CY; Hsu HH; Yu JC; Hsu GC; Hsu KF; Chan DC; Ku CH; Lu TC; Chu CH
Ultraschall Med; 2011 Jan; 32 Suppl 1():S8-13. PubMed ID: 20603785
[TBL] [Abstract][Full Text] [Related]
3. BI-RADS categorization as a predictor of malignancy.
Orel SG; Kay N; Reynolds C; Sullivan DC
Radiology; 1999 Jun; 211(3):845-50. PubMed ID: 10352614
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS.
Heinig J; Witteler R; Schmitz R; Kiesel L; Steinhard J
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):573-8. PubMed ID: 18421795
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic mammography and sonography: concordance of the breast imaging reporting assessments and final clinical outcome].
Lorenzen J; Wedel AK; Lisboa BW; Löning T; Adam G
Rofo; 2005 Nov; 177(11):1545-51. PubMed ID: 16302136
[TBL] [Abstract][Full Text] [Related]
6. Assessment of BI-RADS category 4 lesions detected with screening mammography and screening US: utility of MR imaging.
Strobel K; Schrading S; Hansen NL; Barabasch A; Kuhl CK
Radiology; 2015 Feb; 274(2):343-51. PubMed ID: 25271857
[TBL] [Abstract][Full Text] [Related]
7. The breast imaging reporting and data system: positive predictive value of mammographic features and final assessment categories.
Liberman L; Abramson AF; Squires FB; Glassman JR; Morris EA; Dershaw DD
AJR Am J Roentgenol; 1998 Jul; 171(1):35-40. PubMed ID: 9648759
[TBL] [Abstract][Full Text] [Related]
8. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value.
Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS
Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780
[TBL] [Abstract][Full Text] [Related]
9. Revisiting the mammographic follow-up of BI-RADS category 3 lesions.
Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F
AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047
[TBL] [Abstract][Full Text] [Related]
10. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
[TBL] [Abstract][Full Text] [Related]
11. Prediction of benignity or malignancy of a lesion using BI-RADS.
Masroor I
J Coll Physicians Surg Pak; 2005 Nov; 15(11):686-8. PubMed ID: 16300702
[TBL] [Abstract][Full Text] [Related]
12. Computer-aided classification of BI-RADS category 3 breast lesions.
Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI
Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315
[TBL] [Abstract][Full Text] [Related]
13. Nonpalpable BI-RADS 4 breast lesions: sonographic findings and pathology correlation.
Elverici E; Barça AN; Aktaş H; Özsoy A; Zengin B; Çavuşoğlu M; Araz L
Diagn Interv Radiol; 2015; 21(3):189-94. PubMed ID: 25835079
[TBL] [Abstract][Full Text] [Related]
14. BI-RADS for sonography: positive and negative predictive values of sonographic features.
Hong AS; Rosen EL; Soo MS; Baker JA
AJR Am J Roentgenol; 2005 Apr; 184(4):1260-5. PubMed ID: 15788607
[TBL] [Abstract][Full Text] [Related]
15. [Performance of users in tropical areas with the BI-RADS classification of breast lesions for predicting malignancy].
Gonsu Kamga JE; Moifo B; Sando Z; Guegang Goudjou E; Nko'o Amvene S; Gonsu Fotsin J
Med Sante Trop; 2013; 23(4):439-44. PubMed ID: 24334372
[TBL] [Abstract][Full Text] [Related]
16. BI-RADS 3, 4, and 5 lesions: value of US in management--follow-up and outcome.
Raza S; Chikarmane SA; Neilsen SS; Zorn LM; Birdwell RL
Radiology; 2008 Sep; 248(3):773-81. PubMed ID: 18647850
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value?
Uematsu T; Yuen S; Kasami M; Uchida Y
Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274
[TBL] [Abstract][Full Text] [Related]
18. Role of combined BI-RADS assessment using mammography and sonography for evaluation of incidental hypermetabolic lesions in the breast on 18F-FDG PET-CT.
Lim S; Lee EH; Park JM; Chang YW; Kim HH; Jeong SH
Acta Radiol; 2013 Dec; 54(10):1117-24. PubMed ID: 23864064
[TBL] [Abstract][Full Text] [Related]
19. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Yao MM; Joe BN; Sickles EA; Lee CS
Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
[TBL] [Abstract][Full Text] [Related]
20. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
Br J Radiol; 2018 Jul; 91(1087):20170787. PubMed ID: 29658793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
